Frank Zavrl

About Frank Zavrl

Frank Zavrl is a director at CervoMed.

Form D filings name Frank Zavrl as a director at EIP Pharma.

Frank Zavrl reports to the SEC as a director of 2 public companies, including Puma Biotechnology (PBYI).

Frank Zavrl first appears on SEC filings in 2015.

Experience

This experience comes from SEC filings. The years are when the filings name Frank Zavrl in the role, so the role may have started earlier or lasted longer.

Key Colleagues at Startups

The people Frank Zavrl works with at each company, as listed on that company's latest Form D.

Sources

1. SECEIP Pharma, Inc. Form D, filed Jul 20, 2023
2. SECForms 3, 4 and 5 filed by Frank Zavrl (SEC filer 1652169)